These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9973223)
1. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Bagnato A; Salani D; Di Castro V; Wu-Wong JR; Tecce R; Nicotra MR; Venuti A; Natali PG Cancer Res; 1999 Feb; 59(3):720-7. PubMed ID: 9973223 [TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. Bagnato A; Rosanò L; Di Castro V; Albini A; Salani D; Varmi M; Nicotra MR; Natali PG Am J Pathol; 2001 Mar; 158(3):841-7. PubMed ID: 11238033 [TBL] [Abstract][Full Text] [Related]
3. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro. Salani D; Rosanò L; Di Castro V; Spinella F; Venuti A; Padley RJ; Nicotra MR; Natali PG; Bagnato A Clin Sci (Lond); 2002 Aug; 103 Suppl 48():318S-321S. PubMed ID: 12193113 [TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 acts as a survival factor in ovarian carcinoma cells. Del Bufalo D; Di Castro V; Biroccio A; Salani D; Rosanò L; Spinella F; Bagnato A Clin Sci (Lond); 2002 Aug; 103 Suppl 48():302S-305S. PubMed ID: 12193109 [TBL] [Abstract][Full Text] [Related]
5. Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy. Venuti A; Salani D; Manni V; Poggiali F; Bagnato A FASEB J; 2000 Nov; 14(14):2277-83. PubMed ID: 11053249 [TBL] [Abstract][Full Text] [Related]
6. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Ahmed SI; Thompson J; Coulson JM; Woll PJ Am J Respir Cell Mol Biol; 2000 Apr; 22(4):422-31. PubMed ID: 10745023 [TBL] [Abstract][Full Text] [Related]
7. Role of endothelin-1 in neovascularization of ovarian carcinoma. Salani D; Di Castro V; Nicotra MR; Rosanò L; Tecce R; Venuti A; Natali PG; Bagnato A Am J Pathol; 2000 Nov; 157(5):1537-47. PubMed ID: 11073813 [TBL] [Abstract][Full Text] [Related]
8. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Bagnato A; Tecce R; Moretti C; Di Castro V; Spergel D; Catt KJ Clin Cancer Res; 1995 Sep; 1(9):1059-66. PubMed ID: 9816080 [TBL] [Abstract][Full Text] [Related]
9. Endothelin expression and responsiveness in human ovarian carcinoma cell lines. Moraitis S; Langdon SP; Miller WR Eur J Cancer; 1997 Apr; 33(4):661-8. PubMed ID: 9274451 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
12. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation. Rosanò L; Di Castro V; Spinella F; Decandia S; Natali PG; Bagnato A Exp Biol Med (Maywood); 2006 Jun; 231(6):1132-5. PubMed ID: 16741063 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation. Owe-Young R; Schyvens CG; Qasabian RA; Conigrave AD; Macdonald PS; Williamson DJ Br J Pharmacol; 1999 Jan; 126(1):103-10. PubMed ID: 10051126 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. Grimshaw MJ; Naylor S; Balkwill FR Mol Cancer Ther; 2002 Dec; 1(14):1273-81. PubMed ID: 12516960 [TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991 [TBL] [Abstract][Full Text] [Related]
16. Paracrine regulation of ovarian cancer by endothelin. Moraitis S; Miller WR; Smyth JF; Langdon SP Eur J Cancer; 1999 Sep; 35(9):1381-7. PubMed ID: 10658531 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of ET(A)-receptor stimulation-induced increases in intracellular Ca2+ in SK-N-MC cells. Heinroth-Hoffmann I; Vogelsang M; Schiewe P; Morawietz H; Holtz J; Pönicke K; Brodde OE Br J Pharmacol; 1998 Nov; 125(6):1202-11. PubMed ID: 9863648 [TBL] [Abstract][Full Text] [Related]
18. Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation. Takahashi K; Totsune K; Kitamuro T; Sone M; Murakami O; Shibahara S Clin Sci (Lond); 2002 Aug; 103 Suppl 48():35S-38S. PubMed ID: 12193050 [TBL] [Abstract][Full Text] [Related]
19. [Effect of endothelin-1 and its antagonists on the expression of endothelin receptors mRNA in HSC-T6 cells]. Zhang J; Zhang ZT; Wang Y; Wang P; Li JS; Zhou YZ Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1395-7. PubMed ID: 16318777 [TBL] [Abstract][Full Text] [Related]
20. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]